A novel fragment derived from the beta chain of human fibrinogen, beta43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo.
about
A novel fragment derived from the beta chain of human fibrinogen, beta43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A novel fragment derived from ...... al cells in vitro and in vivo.
@en
A novel fragment derived from ...... al cells in vitro and in vivo.
@nl
type
label
A novel fragment derived from ...... al cells in vitro and in vivo.
@en
A novel fragment derived from ...... al cells in vitro and in vivo.
@nl
prefLabel
A novel fragment derived from ...... al cells in vitro and in vivo.
@en
A novel fragment derived from ...... al cells in vitro and in vivo.
@nl
P2093
P2860
P356
P1476
A novel fragment derived from ...... al cells in vitro and in vivo.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605495
P407
P577
2010-01-12T00:00:00Z